Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (221-230 of 471) with videos related to

Pageof 48
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2019
Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs InvolvedAbdullah S Al Saleh, M Hasib Sidiqi, Eli Muchtar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 13, 2025
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survivalMatthew J Rees, Nadia Toumeh, Angela Dispenzieri, et al.
Transplantation and Cellular Therapy|May 18, 2025
Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell TransplantAnmol Baranwal, Christopher Graham, Khalil Hassan, et al.
American Journal of Hematology|August 12, 2014
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasiasTaxiarchis V Kourelis, Shaji K Kumar, Ronald S Go, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2016
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal GammopathiesLarissa S Higgins, Ronald S Go, David Dingli, et al.
Leukemia|June 17, 2024
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Bone Marrow Transplantation|November 4, 2018
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
American Journal of Hematology|October 9, 2019
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myelomaAbdullah S Al Saleh, M Hasib Sidiqi, Morie A Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple MyelomaSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Pageof 48

Showing results (221-230 of 471) with videos related to

Sort By:
Pageof 48
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2019
Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs InvolvedAbdullah S Al Saleh, M Hasib Sidiqi, Eli Muchtar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 13, 2025
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survivalMatthew J Rees, Nadia Toumeh, Angela Dispenzieri, et al.
Transplantation and Cellular Therapy|May 18, 2025
Comparison of Chimerism Kinetics and Associated Outcomes in Patients Receiving Post-Transplant Cyclophosphamide Versus Methotrexate based GVHD Prophylaxis Following Allogeneic Hematopoietic Cell TransplantAnmol Baranwal, Christopher Graham, Khalil Hassan, et al.
American Journal of Hematology|August 12, 2014
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasiasTaxiarchis V Kourelis, Shaji K Kumar, Ronald S Go, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2016
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal GammopathiesLarissa S Higgins, Ronald S Go, David Dingli, et al.
Leukemia|June 17, 2024
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Bone Marrow Transplantation|November 4, 2018
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
American Journal of Hematology|October 9, 2019
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myelomaAbdullah S Al Saleh, M Hasib Sidiqi, Morie A Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple MyelomaSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Pageof 48